Is FARN.L undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -1.23 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 190.00 GBP, the upside of Faron Pharmaceuticals Oy is -100.65%. This means that FARN.L is overvalued by 100.65%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -1.23 - -1.23 | -1.23 | -100.65% |
P/E | (267.98) - (401.97) | (334.98) | -276.3% |
DDM - Stable | (147.59) - (651.15) | (399.37) | -310.2% |
DDM - Multi | (126.80) - (459.99) | (201.79) | -206.2% |
Market Cap (mil) | 228.36 |
Beta | 2.68 |
Outstanding shares (mil) | 1.20 |
Enterprise Value (mil) | 228.36 |
Market risk premium | 5.98% |
Cost of Equity | 9.55% |
Cost of Debt | 5.00% |
WACC | 9.33% |